NCT02625753View on ClinicalTrials.gov

Codeine Plus Paracetamol Versus Placebo for PRK Post-operative Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

October 31, 2015

Conditions
Myopia
Interventions
DRUG

Codeine

Patients submitted to photorefractive keratectomy received codeine 50mg plus paracetamol 500mg every 6h for 72h after the procedure

DRUG

paracetamol

Patients submitted to photorefractive keratectomy received codeine 50mg plus paracetamol 500mg every 6h for 72h after the procedure

DRUG

placebo

Patients submmitted to photorefractive keratectomy received placebo, in the form of a pill of similar appearance to the comparator, every 6h for 72h after the

Trial Locations (1)

05403-900

Universidade de São Paulo (USP) - Refractive surgery department, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT02625753 - Codeine Plus Paracetamol Versus Placebo for PRK Post-operative Pain | Biotech Hunter | Biotech Hunter